Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fedida

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Expert Opinion on Investigational Drugs|March 21, 2007
Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agentDavid Fedida
Expert Reviews in Molecular Medicine|December 15, 2011
The voltage-gated channel accessory protein KCNE2: multiple ion channel partners, multiple ways to long QT syndromeJodene Eldstrom, David Fedida
International Journal of Molecular Sciences|January 23, 2020
The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic DiseasesMarc Pourrier, David Fedida
Methods in Molecular Biology (Clifton, N.J.)|June 10, 2024
Voltage Clamp Fluorometry: Illuminating the Dynamics of Ion ChannelsDaniel Sastre, David Fedida
The Journal of General Physiology|August 1, 2002
Uncoupling of gating charge movement and closure of the ion pore during recovery from inactivation in the Kv1.5 channelZhuren Wang, David Fedida
Journal of Molecular Graphics & Modelling|August 29, 2009
Modeling of high-affinity binding of the novel atrial anti-arrhythmic agent, vernakalant, to Kv1.5 channelsJodene Eldstrom, David Fedida
Biochimica Et Biophysica Acta|May 18, 2013
Cytoskeletal roles in cardiac ion channel expressionDavid F Steele, David Fedida
Channels (Austin, Tex.)|October 16, 2013
Gating charge movement precedes ionic current activation in hERG channelsSamuel J Goodchild, David Fedida
Progress in Biophysics and Molecular Biology|December 1, 2005
A structural interpretation of voltage-gated potassium channel inactivationHarley T Kurata, David Fedida
Frontiers in Pharmacology|June 22, 2012
Contributions of intracellular ions to kv channel voltage sensor dynamicsSamuel J Goodchild, David Fedida
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Expert Opinion on Investigational Drugs|March 21, 2007
Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agentDavid Fedida
Expert Reviews in Molecular Medicine|December 15, 2011
The voltage-gated channel accessory protein KCNE2: multiple ion channel partners, multiple ways to long QT syndromeJodene Eldstrom, David Fedida
International Journal of Molecular Sciences|January 23, 2020
The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic DiseasesMarc Pourrier, David Fedida
Methods in Molecular Biology (Clifton, N.J.)|June 10, 2024
Voltage Clamp Fluorometry: Illuminating the Dynamics of Ion ChannelsDaniel Sastre, David Fedida
The Journal of General Physiology|August 1, 2002
Uncoupling of gating charge movement and closure of the ion pore during recovery from inactivation in the Kv1.5 channelZhuren Wang, David Fedida
Journal of Molecular Graphics & Modelling|August 29, 2009
Modeling of high-affinity binding of the novel atrial anti-arrhythmic agent, vernakalant, to Kv1.5 channelsJodene Eldstrom, David Fedida
Biochimica Et Biophysica Acta|May 18, 2013
Cytoskeletal roles in cardiac ion channel expressionDavid F Steele, David Fedida
Channels (Austin, Tex.)|October 16, 2013
Gating charge movement precedes ionic current activation in hERG channelsSamuel J Goodchild, David Fedida
Progress in Biophysics and Molecular Biology|December 1, 2005
A structural interpretation of voltage-gated potassium channel inactivationHarley T Kurata, David Fedida
Frontiers in Pharmacology|June 22, 2012
Contributions of intracellular ions to kv channel voltage sensor dynamicsSamuel J Goodchild, David Fedida
Pageof 13